The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

This occurs not only by IgG Fc direct activation of effector pathways, but also by uptake and ingestion of immune complexes by cells, leading to activation of Toll-like receptor sensors of nucleic ...

RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the treatment of ...

These IgG-mediated alloimmune diseases show impaired core fucosylation of the Fc portion of maternal IgG antibodies. This has been associated with enhanced binding to FcγRIIIa receptors on effector ...

More than 1,100 measles cases have been reported in the United States this year, and the highly contagious virus has put ...

FranklinCovey , one of the largest and the most trusted leadership companies in the world, announced today it has been selected as a Training Industry 2025 Top 20 Leadership Training Company for the ...

BeiGene, Ltd. , a global oncology company that will change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US ...

Company’s first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammation Novel ...

The recombinant CD28 and CTLA-4 were expressed and purified in a soluble form, with the extracellular region fused to an IgG Fc region as a tag (CD28 Ig and CTLA-4 Ig). Binding of canine CD28 Ig to ...

Researchers from the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, along with multiple collaborators, have developed ...